Crovalimab
未知生产厂商
Crovalimab is under investigation in clinical trial NCT03157635 (Study to Assess Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Healthy Volunteers and Participants With Paroxysmal Nocturnal Hemoglobinuria).
Crovalimab is under investigation in clinical trial NCT03157635 (Study to Assess Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Healthy Volunteers and Participants With Paroxysmal Nocturnal Hemoglobinuria).
用于未接受过补体抑制剂治疗的阵发性睡眠性血红蛋白尿症（属罕见病）成人和青少年（≥12岁）患者。
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
